Walleye Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Walleye Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-44,084	Closed	-$3M	–	4113
2022 Q3	$3M	Sell	44,084 -62,712	-59%	-$3.46M	0.06%	366
2022 Q2	$3.41M	Buy	106,796 +40,197	+60%	+$1.18M	0.09%	240
2022 Q1	$2.31M	Buy	+66,599	New	+$1.99M	0.06%	330
2021 Q1	–	Sell	-4,762	Closed	-$206	–	1456
2020 Q4	$206	Buy	+4,762	New	+$235K	0.01%	719

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Capital's GBT Position: Q4 2022 in Review

Walleye Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 44,084 shares — an estimated $3M sold.

Walleye Capital first reported a position in GBT in Q4 2020 and held it in 4 quarters. The position peaked at $3.41M in Q2 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Walleye Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 44,084 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3M.
Walleye Capital first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 4 quarters.
Walleye Capital's Global Blood Therapeutics, Inc. position peaked at $3.41M in Q2 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.